These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15949471)

  • 1. Consequences of atrial electrical remodeling for the anti-arrhythmic action of class IC and class III drugs.
    Duytschaever M; Blaauw Y; Allessie M
    Cardiovasc Res; 2005 Jul; 67(1):69-76. PubMed ID: 15949471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol.
    Wijffels MC; Dorland R; Allessie MA
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):178-93. PubMed ID: 10090222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat.
    Blaauw Y; Schotten U; van Hunnik A; Neuberger HR; Allessie MA
    Cardiovasc Res; 2007 Jul; 75(1):89-98. PubMed ID: 17466958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
    Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
    Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class III antiarrhythmic drug action in experimental atrial fibrillation. Differences in reverse use dependence and effectiveness between d-sotalol and the new antiarrhythmic drug ambasilide.
    Wang J; Feng J; Nattel S
    Circulation; 1994 Oct; 90(4):2032-40. PubMed ID: 7923691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat.
    Blaauw Y; Gögelein H; Tieleman RG; van Hunnik A; Schotten U; Allessie MA
    Circulation; 2004 Sep; 110(13):1717-24. PubMed ID: 15364815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol.
    Wijffels MC; Dorland R; Mast F; Allessie MA
    Circulation; 2000 Jul; 102(2):260-7. PubMed ID: 10889140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intrapericardial sotalol and flecainide on transmural atrial electrophysiology and atrial fibrillation.
    van Brakel TJ; Hermans JJ; Accord RE; Schotten U; Smits JF; Allessie MA; Maessen JG
    J Cardiovasc Electrophysiol; 2009 Feb; 20(2):207-15. PubMed ID: 19175851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness.
    Milberg P; Frommeyer G; Ghezelbash S; Rajamani S; Osada N; Razvan R; Belardinelli L; Breithardt G; Eckardt L
    Europace; 2013 May; 15(5):761-9. PubMed ID: 23376977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat.
    Eijsbouts S; Ausma J; Blaauw Y; Schotten U; Duytschaever M; Allessie MA
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):648-54. PubMed ID: 16836716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic effect of vernakalant in electrically remodeled goat atria is caused by slowing of conduction and prolongation of postrepolarization refractoriness.
    van Hunnik A; Lau DH; Zeemering S; Kuiper M; Verheule S; Schotten U
    Heart Rhythm; 2016 Apr; 13(4):964-72. PubMed ID: 26681610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. d,l-Sotalol reverses abbreviated atrial refractoriness and prevents promotion of atrial fibrillation in a canine model with left ventricular dysfunction induced by atrial tachypacing.
    Sakamoto T; Fujiki A; Nakatani Y; Sakabe M; Mizumaki K; Hashimoto N; Inoue H
    Circ J; 2009 Oct; 73(10):1820-8. PubMed ID: 19713653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of pharmacologic cardioversion of atrial fibrillation by Class I drugs.
    Allessie MA; Wijffels MC; Dorland R
    J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S69-77. PubMed ID: 9727679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Flecainide and Ibutilide Alone and in Combination to Terminate and Prevent Recurrence of Atrial Fibrillation.
    Burashnikov A; Di Diego JM; Patocskai B; Echt DS; Belardinelli L; Antzelevitch C
    Circ Arrhythm Electrophysiol; 2024 Jan; 17(1):e012454. PubMed ID: 38146652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiologic actions of dl-sotalol in patients with persistent atrial fibrillation.
    Tse HF; Lau CP
    J Am Coll Cardiol; 2002 Dec; 40(12):2150-5. PubMed ID: 12505228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: insights into the mechanism of the superior efficacy of amiodarone.
    Shinagawa K; Shiroshita-Takeshita A; Schram G; Nattel S
    Circulation; 2003 Mar; 107(10):1440-6. PubMed ID: 12642367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacological response of ischemia-related atrial fibrillation in dogs: evidence for substrate-specific efficacy.
    Rivard L; Sinno H; Shiroshita-Takeshita A; Schram G; Leung TK; Nattel S
    Cardiovasc Res; 2007 Apr; 74(1):104-13. PubMed ID: 17316585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of ventricular fibrillation by flecainide, verapamil, and sotalol: an experimental study.
    Chorro FJ; Cánoves J; Guerrero J; Mainar L; Sanchis J; Such L; López-Merino V
    Circulation; 2000 Apr; 101(13):1606-15. PubMed ID: 10747356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation.
    Wijffels MC; Kirchhof CJ; Dorland R; Power J; Allessie MA
    Circulation; 1997 Nov; 96(10):3710-20. PubMed ID: 9396475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.